News

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...
An analysis of mpox virus genomes from individuals infected between 2018 and 2023 has provided insights into how the virus ...
In March 2025, the Advisory Committee on Dangerous Pathogens (ACDP) advised that clade I mpox no longer meets the criteria for a high consequence infectious disease (HCID) and recommended derogation.
The investigators at How to Survive explain how Mpox attacks the body and essential steps to survive infection.
NanoViricides, Inc. is a publicly traded clinical-stage company focused on creating special purpose nanomaterials for antiviral therapy. The company's innovative nanoviricide class of drug candidates ...
The figure reflects the data as of epidemiological week 25 of 2025, which underscores the disproportionate disease burden on ...
In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.
Continuing to vaccinate for mpox through a routine targeted program for gay and bisexual men delivered by sexual health ...
THE 53rd Infantry Battalion (53IB) has spearheaded an mpox (monkeypox) Awareness Seminar demonstrating its commitment to ...
Thailand reports 40 mpox cases in 2023; sexual transmission is the main cause. Vigilant monitoring and advice on safe practices continue.
MATI CITY, Davao Oriental (PIA) – As the province of Davao Oriental reported its first confirmed Monkeypox (Mpox) case, the ...